Freedom of Information request on the number of batches of the Moderna and Janssen vaccines were authorised under Regulation 174 and the conditions for authorisation ( FOI 21/1187)
Published 26 May 2022
© Crown copyright 2022
This publication is licensed under the terms of the Open Government Licence v3.0 except where otherwise stated. To view this licence, visit nationalarchives.gov.uk/doc/open-government-licence/version/3 or write to the Information Policy Team, The National Archives, Kew, London TW9 4DU, or email: psi@nationalarchives.gov.uk.
Where we have identified any third party copyright information you will need to obtain permission from the copyright holders concerned.
This publication is available at https://www.gov.uk/government/publications/freedom-of-information-responses-from-the-mhra-week-commencing-8-november-2021/freedom-of-information-request-on-the-number-of-batches-of-the-moderna-and-janssen-vaccines-were-authorised-under-regulation-174-and-the-conditions-fo
FOI 21/1187
11th November 2021
Dear,
Thank you for your email.
Please find below our responses to your questions
- No batches of the Moderna and Janssen vaccines were authorised under Regulation 174, as these were granted marketing authorisations following a European Commission (EC) decision. Information concerning this has been sent in response to a previous request.
- Conditions for Authorisation linked below are updated as needed on a regular basis:
- Please see answer to question 2.
- Additional batches that have been used in the UK through the marketing authorisations that have been granted for the Pfizer and AstraZeneca vaccines do not need to be listed in the Conditions of Authorisation, which refers to batches authorised for use under Regulation 174.
- Please see answers above.
Kind regards,
MHRA Customer Service Centre